Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;158(3):700-704.
doi: 10.1002/ijgo.14062. Epub 2021 Dec 23.

Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method

Montas Laporte  1 , Charles M Charles  1 , Sherly Metelus  1 , Alessandra Peloggia  1 , Gabriela de O Paez  1 , Cassia T Juliato  1 , Luis Bahamondes  1
Affiliations

Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method

Montas Laporte et al. Int J Gynaecol Obstet. 2022 Sep.

Abstract

Objective: To assess the reasons provided by women for choosing the use of the 52 mg levonorgestrel intrauterine system (LNG-IUS) as a contraceptive method.

Methods: We conducted a cross sectional study from January 2021 to August 2021 at the University of Campinas, Campinas, SP, Brazil. Women who had never used the 52 mg LNG-IUS and were requesting it for contraception answered a questionnaire asking for their sociodemographic characteristics, the last contraceptive method in use, how they received information about the device, and their main reasons for choosing the method.

Results: We enrolled 516 women, 365 (70.7%) of whom were under the age of 35 and 352 (68.2%) of whom were parous. The last contraceptive method in use was a short-acting reversible method among 387 (80.8%) women, 454 (88%) reported that they wanted to use the IUS only for contraception, and the main source of information was their health care providers. The main reported reasons for choosing the method were because it is safe, has high contraceptive efficacy, and reduces menstrual bleeding.

Conclusion: Health care providers should continue their efforts to provide guidance about the LNG-IUS, including the non-contraceptive benefits, which may contribute to a reduction in the number of unplanned pregnancies.

Keywords: Brazil; hormonal-IUD; levonorgestrel intrauterine system; reasons to use; women characteristics.

PubMed Disclaimer

References

REFERENCES

    1. World Health Organization. WHO statement on levonorgestrel-releasing intrauterine device nomenclature. World Health Organization. 2021. Available at: https://apps.who.int/iris/handle/10665/340378 Accessed July 20, 2021
    1. Bellizzi S, Mannava P, Nagai M, Sobel HL. Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries. Contraception. 2020;101:26-33.
    1. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998-2007.
    1. Teal SB, Turok DK, Chen BA, Kimble A, Olariu AI, Creinin MD. Five-year contraceptive efficacy and safety of a levonorgestrel 52-mg intrauterine system. Obstet Gynecol. 2019;133:63-70.
    1. Carr BR, Thomas MA, Gangestad A, Eisenberg DL, Olariu A, Creinin MD. Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation. Contraception. 2021;103:26-31.

Substances

LinkOut - more resources